Quidel Corporation (QDEL) |
|
81.13 -1.11 (-1.35%)
|
02-20 16:00 |
|
Open: |
81.57 |
Pre. Close: |
82.24 |
|
High:
|
81.7336 |
Low:
|
78.68 |
|
Volume:
|
126,375 |
Market Cap:
|
3302M |
|
|
|
|
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
81.834 - 82.231 |
82.231 - 82.623 |
|
Low:
|
77.523 - 78.016 |
78.016 - 78.501 |
|
Close:
|
80.195 - 80.995 |
80.995 - 81.785 |
|
Technical analysis |
as of: 2020-02-20 4:43:07 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 96.62 One year: 112.85 |
| Support: |
Support1: 76.03 Support2: 71.90 |
| Resistance: |
Resistance1: 82.72 Resistance2: 96.62 |
| Pivot: |
78.96  |
| Moving Average: |
MA(5): 80.88 MA(20): 78.89
MA(100): 69.01 MA(250): 64.25 |
| MACD: |
MACD(12,26): 1.44 Signal(9): 1.27 |
| Stochastic oscillator: |
%K(14,3): 81.29 %D(3): 79.64 |
| RSI: |
RSI(14): 60.18 |
| 52-week: |
High: 82.72 Low: 52.49 Change(%): 19.8 |
| Average Vol(K): |
3-Month: 22375 10-Days: 20552 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.QDEL has closed below upper band by 19.0%. Bollinger Bands are 10.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2020-01-28
Quidel to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on February 12th, 2020
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fourth quarter and full year 2019 financial results after market close on Wednesday, February 12, 2020. Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m.
2020-01-09
Quidel Announces Preliminary Revenue for Fourth Quarter 2019
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects revenues in the fourth quarter of 2019 to be in the range of $151 million to $152 million. “We had another great fourth quarter, and a good year. Operationally, 2019 was notable in that we completed the integration of the Triage business, unlocked synergies ahead of schedule, a
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Diagnostics Research |
| Shares Out. (M) |
41.65 |
| Shares Float (M) |
37.79 |
|
% Held by Insiders
|
11.95 |
|
% Held by Institutions
|
92.07 |
|
Shares Short (K)
|
2340 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
1.800 |
|
Book Value (p.s.)
|
12.830 |
|
PEG Ratio
|
3.73 |
|
Profit Margin
|
14.51 |
|
Operating Margin
|
19.13 |
|
Return on Assets (ttm)
|
7.4 |
|
Return on Equity (ttm)
|
16.2 |
|
Qtrly Rev. Growth
|
7.7 |
|
Gross Profit (p.s.)
|
7.668 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
3.517 |
|
Qtrly Earnings Growth
|
49.50 |
|
Operating Cash Flow (M)
|
129.98 |
|
Levered Free Cash Flow (M)
|
87.68 |
Stock Valuations |
|
P/E
|
45.07 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
6.32 |
|
P/S
|
6.33 |
|
P/CF
|
26.00 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
